Trust, transparency, and accountability in health and pharmaceutical systems

Abstract Trust is essential for the effectiveness of public health and pharmaceutical systems, ensuring the availability of safe, effective, and affordable medicines globally. The COVID-19 pandemic highlighted the critical role of public trust, showing how its erosion can undermine health efforts, leading to increased vaccine hesitancy and the adoption of ineffective or unsafe remedies. Trust enables collective action, crucial for public health measures, and public support for policies improving medicine access depends on trust in pharmaceutical companies’ commitment to fair and affordable pricing. This thematic collection of the Journal of Pharmaceutical Health Services Research explores the importance of transparency and accountability in pharmaceutical systems. Addressing corruption risks and conflicts of interest is vital to ending health inequalities and ensuring the legitimacy and epistemic authority of health systems. This thematic collection aims to advance the dialogue on the necessity of transparent and accountable health and pharmaceutical systems that are trustworthy and to deepen our understanding of potential trust cleavages within these systems.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical Health Services Research
Published
2024-12-06
DOI
https://doi.org/10.1093/jphsr/rmaf003
Citations
1
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trust, transparency, and accountability in health and pharmaceutical systems

Alison Thompson
1 citations
Journal of Pharmaceutical Health Services Research
Pharmaceutical Economics and Policy
1.13
article

Trust, transparency, and accountability in health and pharmaceutical systems

Alison Thompson
article en
1 citations

Abstract

Abstract Trust is essential for the effectiveness of public health and pharmaceutical systems, ensuring the availability of safe, effective, and affordable medicines globally. The COVID-19 pandemic highlighted the critical role of public trust, showing how its erosion can undermine health efforts, leading to increased vaccine hesitancy and the adoption of ineffective or unsafe remedies. Trust enables collective action, crucial for public health measures, and public support for policies improving medicine access depends on trust in pharmaceutical companies’ commitment to fair and affordable pricing. This thematic collection of the Journal of Pharmaceutical Health Services Research explores the importance of transparency and accountability in pharmaceutical systems. Addressing corruption risks and conflicts of interest is vital to ending health inequalities and ensuring the legitimacy and epistemic authority of health systems. This thematic collection aims to advance the dialogue on the necessity of transparent and accountable health and pharmaceutical systems that are trustworthy and to deepen our understanding of potential trust cleavages within these systems.

Journal of Pharmaceutical Health Services ResearchVol. 16(1)
3M (United States) (US), University of Toronto (CA)
Openalex Percentile: Top 10%
Pharmaceutical Economics and Policy
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.